XELJANZ XR 11 mg Extended Release Tablet 2025 Price


191204 people have viewed this drug in the last 60 days

Scientific Name is: TOFACITINIB






Updated 2025-06-04



Is there any problem with this page?
Please contact us and we will work to resolve the issue as soon as possible
Click here to report a problem
Last Update 2023-01-19
Register Year 2018
Product Type Human
Drug Type NCE
Scientific Name TOFACITINIB
Trade Name XELJANZ XR 11 mg Extended Release Tablet
Strength Unit mg
Pharmaceutical Form modified-release tablet
Administration Route Oral use
Atc Code1 L04AA29 
Atc Code2
Size 0
Size Unit
Package Types Bottle
Package Size 30
Legal Status Prescription
Product Control Uncontrolled
Distribute Area Hospital
Public price $4646.9
Shelf Life 48 Months
Marketing Company PFIZER
Marketing Country United States
Manufacture Name PFIZER PHARMACEUTICAL LLC BARCELONETA OPERATIONS
Manufacture Country United States
Secondry package manufacture
Main Agent ALNAGHI COMPANY
Secosnd Agent Pfizer Saudi Trading
Third Agent
Visits 191204




Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly




Do not forget that there are poor patients who depend on you to determine the real price
We wish a speedy recovery for your patients ❤🤍

Click here to view alternatives to this drug


Caution and disclaimer of responsibility for all medical information, prices and scientific materials that we publish on the Global Drugs Directory website, its purpose is only to increase medical awareness and promote health culture among users
Medicines similar to XELJANZ XR 11 mg Extended Release Tablet
Name Price Visits Updated
XELJANZ XR 11 mg Extended Release Tablet $4646.9 191204 visits 2023-01-19
XELJANZ 5 mg film-coated tablet $4646.9 146142 visits 2023-02-19